Dec. 30 at 4:00 AM
$SLS Blows my mind that shorts are going to try to continue to attack this. 217M float, market cap is 600M. GPSs by itself is worth a floor of 10 billion, that's 45$ a share. Then factor in SLS 009 whose trial also exceeded expectations; the potential drug cocktail SLS 009 combined with GPS regal. Orphan drug treatments make a ton of money (look up Fabrazyme and its history). They have 75M in cash and average a burn of 7M a quarter, 13 employees. Biotech is hot, and immunotherapies are even hotter, than put cancer treatment with no toxic profile into that mix. (BAT is toxic as hell) You're out of your fucking mind to short this. Plus 26% tute ownership, Black Rock being one of the top dogs. Out of all the crap on the market to short, your going to pick this? Hold it through 2026, save on your capital gains. Your shares are going to be converted into
$PFE $MRK $ABBV or another big pharma player. This shits going to blow up.
